United States · FDA National Drug Code directory
Rifadin
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 0068-0660_5cebbeae-b984-4e38-a050-896320bf049c
- Product NDC
- 0068-0660
- Form
- KIT
- Composition / generic term
- rifampicin
- Labeler
- Sanofi-Aventis U.S. LLC
- Marketing category
- UNAPPROVED DRUG FOR USE IN DRUG SHORTAGE
- Marketing start / end (source format)
- 20260803
- Source listing expiry
- 20271231
Source-listed ingredients
Separate ingredient quantities are not available in this snapshot. Any composition term above is preserved as source text.
These values do not establish equivalence or a dose recommendation.
Packages
- 1 KIT in 1 CARTON (0068-0660-50) * 10 mL in 1 VIAL (0068-0600-01) * 10 mL in 1 AMPULE (0068-0610-10) · 0068-0660-50
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →